0000899243-21-013808.txt : 20210329
0000899243-21-013808.hdr.sgml : 20210329
20210329163510
ACCESSION NUMBER: 0000899243-21-013808
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210325
FILED AS OF DATE: 20210329
DATE AS OF CHANGE: 20210329
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rubin Marc
CENTRAL INDEX KEY: 0001412377
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31791
FILM NUMBER: 21782130
MAIL ADDRESS:
STREET 1: C/O TITAN PHARMACEUTICALS, INC.
STREET 2: 400 OYSTER POINT BLVD., STE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GALECTIN THERAPEUTICS INC
CENTRAL INDEX KEY: 0001133416
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043562325
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD
STREET 2: SUITE 240
CITY: NORCROSS
STATE: GA
ZIP: 30071
BUSINESS PHONE: 678-620-3186
MAIL ADDRESS:
STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD
STREET 2: SUITE 240
CITY: NORCROSS
STATE: GA
ZIP: 30071
FORMER COMPANY:
FORMER CONFORMED NAME: PRO PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010612
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-25
0
0001133416
GALECTIN THERAPEUTICS INC
GALT
0001412377
Rubin Marc
C/O GALECTIN THERAPEUTICS INC.
4960 PEACHTREE INDUSTRIAL BLVD., STE 240
NORCROSS
GA
30071
1
0
0
0
Stock option (right to buy)
2.11
2021-03-25
4
A
0
40000
0.00
A
2031-03-25
Common Stock
40000
40000
D
Stock option (right to buy)
2.11
2021-03-25
4
A
0
70000
0.00
A
2031-03-25
Common Stock
70000
70000
D
The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan.
Such options vest 100% on March 31, 2022.
Such options vest when (i) the Company has received the interim results of its NAVIGATE clinical trial and (ii) makes a public announcement that it has received the interim results.
(1) The reporting person is president and director of Ed Uihlein Family Foundation, a not-for-profit corporation. The reporting person has no pecuniary interest in the shares, however, he shares voting and dispositive power over the shares and, therefore, remains the beneficial owner of the shares solely for the purposes of Section 13(d) of the Securities Exchange Act of 1934.
/s/ Jack W. Callicutt, by power of attorney
2021-03-29